PATENT CLAIM ANALYSIS

Application Number: 15744712
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "016800"]

Abstract:
Provided are fusion polypeptides comprising fragments from a first and a second FGF family member, nucleic acids encoding the fusion polypeptides, vectors and host cells containing the same, and methods of making and using such compositions in the treatment of FGF-related diseases, disorders, and conditions.

Claim (Index 42):
The fusion polypeptide of  claim 1 ,  12  or  23 , wherein the N-terminus of said fusion polypeptide is further modified by a polyethylene glycol (PEG).

Metadata:
- Claim Count in Document: 112.0
- Percentile: 86.0
- Lexical Diversity: 1.37838
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15107101', '14380277', '13515429', '15660116', '10251947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7732946941547962
- 35 USC 102 Novelty (BERT): 0.553180990219652
- Combined Prediction Score: 0.7512833237612818
- Mean Citation Score: 314.01251
- Max Citation Score: 411.7714
- Similarity Product: 362.4804675631762

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test